NeoPharm Co., Ltd. engages in the development, manufacture, and sale of skin care products. It offers products for sensitive and dry skin, and the treatment of atopic dermatitis and psoriasis. Its brands include ATOPALM, Real Barrier, ZEROID, and Derma-B. The company was founded on July 1, 2000 and is headquartered in Daejeon, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company